Incyte INCY Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Product | ||||||
| ICLUSIG | $34.39M+5.1% | $35.46M+20.0% | $34.22M+25.0% | $37.58M+26.3% | $32.73M+21.8% | |
| JAKAFI | $816.66M+6.9% | $757.76M+6.8% | $828.24M+7.1% | $791.07M+6.7% | $763.79M+8.2% | |
| JAKAVI | $124.19M+13.2% | $105.56M+14.6% | $130.23M+14.0% | $125.65M+8.6% | $109.71M+10.5% | |
| Milestone and contract revenues | $11.2M+124% | $17M— | $100M— | $45M+150% | $5M— | |
| MINJUVI/MONJUVI | $53.69M+72.5% | $49.23M+66.6% | $41.91M+27.7% | $41.99M+33.6% | $31.13M0.0% | |
| NIKTIMVO | $60.31M+66.8% | $55.09M+305% | $56.04M— | $45.83M— | $36.15M— | |
| OLUMIANT | $38.48M+14.9% | $36.41M+18.2% | —— | $37.11M+6.7% | $33.48M+5.6% | |
| OPZELURA | $449.74M+173% | $143.02M+20.5% | $207.28M+28.3% | $187.97M+35.0% | $164.5M+35.2% | |
| Other | $5.33M+314% | $3.25M+156% | $3.47M+942% | $1.86M+348% | $1.29M+46.9% | |
| PEMAZYRE | $23.42M+5.5% | $22.54M+22.3% | $23.35M+0.9% | $22.74M+10.1% | $22.19M+9.5% | |
| TABRECTA | $6.69M+0.9% | $5.98M-6.7% | $7.14M+13.6% | $6.51M+9.9% | $6.63M+25.2% | |
| ZYNYZ | $49.95M+460% | $41.39M+1,276% | $31.75M+2,212% | $22.67M+3,167% | $8.92M+1,270% | |
| Total revenues by Geography | ||||||
| Europe | $105.13M+33.4% | $92.43M+34.7% | $75.99M-14.4% | $100.31M+50.9% | $78.83M+47.1% | |
| Other countries | $8.8M+102% | $8.78M+225% | $6.08M+143% | $4.41M+223% | $4.35M+280% | |
| United States | $1.56B+37.8% | $1.17B+19.3% | $1.42B+28.0% | $1.26B+17.9% | $1.13B+14.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Incyte break its business down?
- Incyte (INCY) reports total revenues by product across 12 parts — ICLUSIG, JAKAFI, JAKAVI, Milestone and contract revenues and MINJUVI/MONJUVI. Each is extracted from the segment footnotes and tracked over time.
- Where does Incyte's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Incyte's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
